Geoff Oxnard

Geoff Oxnard

Chief Tech/Sci/R&D Officer at BLOSSOMHILL THERAPEUTICS, INC.

Net worth: 331 512 $ as of 29/09/2026

49 year
Health Technology
Consumer Services

Profile

Geoff Oxnard is Chief Medical Officer & Executive Vice President at Blossomhill Therapeutics, Inc. since 2025.
Formerly, Dr. Oxnard was Vice President & Global Head-Thoracic Cancers at Eli Lilly & Co. from 2023 to 2025 and Senior Vice President & Head-Clinical Development at F.
Hoffmann-La Roche Ltd. from 2021 to 2023.
Education includes undergraduate studies at Harvard University and a doctorate from Pritzker School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/08/2026 17,785 ( 0.06% ) 331 512 $ 29/09/2026

Geoff Oxnard active positions

CompaniesPositionStart
BLOSSOMHILL THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/12/2024

Former positions of Geoff Oxnard

CompaniesPositionEnd
ELI LILLY AND COMPANY Corporate Officer/Principal 31/12/2024
Corporate Officer/Principal 31/08/2023
See the detail of Geoff Oxnard's experience

Education of Geoff Oxnard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology